• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液学标志物作为多发性硬化症进展的预后指标

Hematological markers as prognostic indicators in multiple sclerosis progression.

作者信息

Poursadeghfard Maryam, Shiati Samin, Salehi Mohammad Saied, Khani Aryan, Vafaeian Soheil, Bayat Mahnaz, Hooshmandi Etrat

机构信息

Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.

出版信息

Biomark Med. 2025 Jan;19(1):5-12. doi: 10.1080/17520363.2024.2441106. Epub 2024 Dec 17.

DOI:10.1080/17520363.2024.2441106
PMID:39686852
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11731226/
Abstract

AIMS

To evaluate routine blood count parameters as diagnostic and prognostic markers in Multiple Sclerosis (MS) progression.

PATIENTS/METHODS: 182 patients with Relapsing-Remitting MS (RRMS) and 60 with Secondary Progressive MS (SPMS) were analyzed for blood parameters.

RESULTS

In RRMS, the Expanded Disability Status Scale (EDSS) score correlated positively with Red Cell Distribution Width (RDW). In SPMS, the EDSS score correlated positively with White Blood Cell count (WBC) and Mean Platelet Volume (MPV). RDW predicted higher EDSS scores in RRMS, while MPV was a predictor in SPMS. Elevated MPV levels characterized the increased risk of transitioning from RRMS to SPMS.

CONCLUSIONS

Elevated MPV may serve as a significant indicator of disease progression from RRMS to SPMS, emphasizing its potential clinical relevance.

摘要

目的

评估血常规参数作为多发性硬化症(MS)病情进展的诊断和预后标志物。

患者/方法:对182例复发缓解型多发性硬化症(RRMS)患者和60例继发进展型多发性硬化症(SPMS)患者的血液参数进行分析。

结果

在RRMS中,扩展残疾状态量表(EDSS)评分与红细胞分布宽度(RDW)呈正相关。在SPMS中,EDSS评分与白细胞计数(WBC)和平均血小板体积(MPV)呈正相关。RDW可预测RRMS患者更高的EDSS评分,而MPV是SPMS的预测指标。MPV水平升高是RRMS向SPMS转变风险增加的特征。

结论

MPV升高可能是RRMS向SPMS疾病进展的重要指标,强调了其潜在的临床相关性。

相似文献

1
Hematological markers as prognostic indicators in multiple sclerosis progression.血液学标志物作为多发性硬化症进展的预后指标
Biomark Med. 2025 Jan;19(1):5-12. doi: 10.1080/17520363.2024.2441106. Epub 2024 Dec 17.
2
Teriflunomide for multiple sclerosis.特立氟胺用于治疗多发性硬化症。
Cochrane Database Syst Rev. 2012 Dec 12;12:CD009882. doi: 10.1002/14651858.CD009882.pub2.
3
Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis.用于多发性硬化症的免疫调节剂和免疫抑制剂:一项网状Meta分析
Cochrane Database Syst Rev. 2013 Jun 6;2013(6):CD008933. doi: 10.1002/14651858.CD008933.pub2.
4
The impact of changing diagnostic criteria on disability in a Brazilian multiple sclerosis cohort.诊断标准的变化对巴西多发性硬化症队列中残疾状况的影响。
Arq Neuropsiquiatr. 2025 Jun;83(6):1-9. doi: 10.1055/s-0045-1809662. Epub 2025 Jun 25.
5
The impact of increasing neurological disability of multiple sclerosis on health utilities: a systematic review of the literature.多发性硬化症神经功能障碍程度增加对健康效用的影响:文献系统评价。
J Med Econ. 2010 Mar;13(1):78-89. doi: 10.3111/13696990903543085.
6
Teriflunomide for multiple sclerosis.特立氟胺用于治疗多发性硬化症。
Cochrane Database Syst Rev. 2016 Mar 22;3(3):CD009882. doi: 10.1002/14651858.CD009882.pub3.
7
Peripheral HLA-DRCD141 Classical Monocytes Predict Relapse Risk and Worsening in Multiple Sclerosis.外周血 HLA-DR⁺CD14⁺ 经典单核细胞可预测多发性硬化症的复发风险及病情恶化。
Neurol Neuroimmunol Neuroinflamm. 2025 Sep;12(5):e200426. doi: 10.1212/NXI.0000000000200426. Epub 2025 Jul 3.
8
A meta-analysis of the efficacy and tolerability of interferon-β in multiple sclerosis, overall and by drug and disease type.多发性硬化症中干扰素-β的疗效和耐受性的荟萃分析,整体及按药物和疾病类型。
Clin Ther. 2010 Oct;32(11):1871-88. doi: 10.1016/j.clinthera.2010.10.006.
9
Correspondence of MRI and nTMS With EDSS in Multiple Sclerosis: Longitudinal Follow-Up Study.多发性硬化症中MRI和nTMS与扩展残疾状态量表(EDSS)的相关性:纵向随访研究
Ann Clin Transl Neurol. 2025 Jun;12(6):1240-1255. doi: 10.1002/acn3.70041. Epub 2025 Apr 17.
10
Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis.复发缓解型多发性硬化症中与复发活动无关的进展(PIRA)的标准化定义
JAMA Neurol. 2025 Apr 14. doi: 10.1001/jamaneurol.2025.0495.

本文引用的文献

1
Markedly Increased Mean Platelet Volume in Bacterial Meningitis.细菌性脑膜炎的血小板平均体积显著增加。
Clin Lab. 2023 Dec 1;69(12). doi: 10.7754/Clin.Lab.2023.230631.
2
Lymphocyte Counts and Multiple Sclerosis Therapeutics: Between Mechanisms of Action and Treatment-Limiting Side Effects.淋巴细胞计数与多发性硬化症治疗:在作用机制与治疗限制性副作用之间
Cells. 2021 Nov 15;10(11):3177. doi: 10.3390/cells10113177.
3
White blood cell count profiles in multiple sclerosis during attacks before the initiation of acute and chronic treatments.
多发性硬化症在开始急性和慢性治疗前的发作期间的白细胞计数谱。
Sci Rep. 2021 Nov 16;11(1):22357. doi: 10.1038/s41598-021-01942-8.
4
Mean platelet volume in children with systemic lupus erythematosus.儿童系统性红斑狼疮的平均血小板体积。
Lupus. 2021 Jan;30(1):103-108. doi: 10.1177/0961203320965695. Epub 2020 Oct 22.
5
Cerebrospinal Fluid Testing for Multiple Sclerosis.脑脊液检测多发性硬化症。
Clin Lab Med. 2020 Sep;40(3):369-377. doi: 10.1016/j.cll.2020.06.002. Epub 2020 Jul 2.
6
Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis.疾病修饰治疗对多发性硬化症患者外周白细胞的影响。
J Neurol. 2021 Jul;268(7):2379-2389. doi: 10.1007/s00415-019-09690-6. Epub 2020 Feb 8.
7
Mean Platelet Volume (MPV): New Perspectives for an Old Marker in the Course and Prognosis of Inflammatory Conditions.平均血小板体积(MPV):炎症病程和预后标志物的新视角。
Mediators Inflamm. 2019 Apr 17;2019:9213074. doi: 10.1155/2019/9213074. eCollection 2019.
8
The neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios are independently associated with neurological disability and brain atrophy in multiple sclerosis.中性粒细胞与淋巴细胞比值及单核细胞与淋巴细胞比值与多发性硬化症的神经功能障碍和脑萎缩独立相关。
BMC Neurol. 2019 Feb 12;19(1):23. doi: 10.1186/s12883-019-1245-2.
9
Multiple sclerosis.多发性硬化症。
Nat Rev Dis Primers. 2018 Nov 8;4(1):43. doi: 10.1038/s41572-018-0041-4.
10
Application of the 2017 Revised McDonald Criteria for Multiple Sclerosis to Patients With a Typical Clinically Isolated Syndrome.2017 年修订的多发性硬化症 McDonald 标准在典型临床孤立综合征患者中的应用。
JAMA Neurol. 2018 Nov 1;75(11):1392-1398. doi: 10.1001/jamaneurol.2018.2160.